Schrodinger’s platform for accelerated drug development and materials discovery
Snapshot Schrodinger (SDGR) is offering 10m shares at $14-16 for a $1B market cap. We expect the shares to perform well in part given that they are backed by two notable investors, David Shaw and Bill Gates, and they have a strong position in enabling new drug discovery and the development of new materials. It…
The post Schrodinger’s platform for accelerated drug development and materials discovery appeared first on IPO Candy.